Secondary Offerings

Secondaries announced 10.20.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: DXP Enterprises, Inc. Symbol: DXPE Price: Last trade $24.03 Trade Date: 10/27 Shares: 2.7 million Underwriter(s)Stephens, Inc. Co Manager(s)Blair & Co.,[…]

Secondaries announced 10.19.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Organovo Symbol: ONVO Price: Last trade $3.49 Description: Re-offer $2.75-$3.00 Trade Date: 10/20 Shares: 7.2 million Underwriter(s)Jefferies, Evercore ISI, Raymond James[…]

Secondaries announced 10.18.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Twilio, Inc. Symbol: TWLO Price: Last trade $45.07 Trade Date: 10/21 Shares: 7 million Underwriter(s)Goldman Sachs, J.P. Morgan CoManager(s)Allen & Co.,[…]

Secondaries announced 10.17.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Nektar Therapeutics Symbol: NKTR Price: Last trade $15.67 Trade Date: 10/19 Shares: 11.2 million Underwriter(s)J.P. Morgan Rating=Subscription Needed

Secondaries announced 10.13.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: RSP Permian, Inc. Symbol: RSPP Price: Last trade $41.75 Description: Re-offer range $38.75-$40.75 Trade Date: 10/14 Shares: 20 million Underwriter(s)Barclays, RBC[…]

Secondaries announced 10.6.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: AxoGen, Inc. Symbol: AXGN Price: Last trade $8.24 Description: No re-offer range available Trade Date: 10/7 Shares: 1.8 million Underwriter(s)JMP Securities[…]

Secondaries announced 10.5.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Idera Pharmaceuticals Symbol: IDRA Price: Last trade $2.61 Trade Date: 10/7 Shares: 19.2 million Underwriter(s)J.P. Morgan, Goldman Sachs Rating=Subscription Needed

Secondaries announced 10.4.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Advanced Accelerator Applications S.A. Symbol: AAAP Price: Last trade $37.40 Trade Date: 10/6 Shares: 3.34 million Underwriter(s) J.P. Morgan, Jefferies, Wells[…]

Secondaries announced 9.29.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: VolitionRX Symbol: VNRX Price: Last trade $5.58 Description: No re-offer available Trade Date: 9/30 Shares: 1.8 million Underwriter(s)National Securities Corporation Rating=Subscription[…]

Secondaries announced 9.27.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Independence Realty Trust Symbol: IRT Price: Last trade $10.61 Trade Date: 9/30 Shares: 25 million Underwriter(s)Citigroup Rating=Subscription Needed Company: Foamix Pharmaceuticals[…]

Secondaries announced 9.21.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Sarepta Therapeutics, Inc. Symbol: SRPT Price: Last trade $56.09 Trade Date: 9/23 Shares: 4 million Underwriter(s) J.P. Morgan, Goldman Sachs, Credit[…]

Secondaries announced 9.20.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: CareDx Symbol: CDNA Price: Last trade $4.30 Description: No re-offer available Trade Date: 9/21 Shares: 2.3 million Underwriter(s) Piper Jaffray Rating=Subscription[…]

Secondaries announced 9.19.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Aquinox Symbol: AQXP Price: Last trade $12.68 Description: No re-offer range available Trade Date: 9/20 Shares: 4.73 million Underwriter(s) Leerink Partners,[…]

Secondaries announced 9.15.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Platform Specialty Products Corporation Symbol: PAH Price: Last trade $8.96 Trade Date: 9/16 Shares: 39 million Underwriter(s) Credit Suisse, UBS Rating=Subscription[…]

Secondaries announced 9.14.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Star Bulk Carriers Symbol: SBLK Price: Last trade $4.68 Description: Re-offer $4.30-$4.55 Trade Date: 9/15 Shares: 11 million Underwriter(s) Citigroup, Clarksons[…]

Secondaries announced 09-13.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Callidus Software Inc. Symbol: CALD Price: Last trade $18.91 Trade Date: 9/16 Shares: 4 million Underwriter(s) Piper Jaffray, Credit Suisse Co[…]

Secondaries announced 9.12.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: VimpelCom Ltd. Symbol: VIP Price: Last trade $3.90 Trade Date: 9/16 Shares: 142.5 million ADSs Underwriter(s) Morgan Stanley, J.P. Morgan, Citigroup,[…]

Secondaries announced 9.8.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: IMPAC Mortgage Symbol: IMH Price: Last trade $16.87 Trade Date: TBD Shares: 2.5 million Underwriter(s) JMP Securities Rating=Subscription Needed Company: CoLucid[…]

Secondaries announced 9.7.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Sage Therapeutics, Inc. Symbol: SAGE Price: Last trade $41.34 Trade Date: 9/9 Shares: 3.63 million Underwriter(s) J.P. Morgan, Goldman Sachs Co[…]

Secondaries announced 9.6.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Proteostasis Therapeutics Symbol: PTI Price: Last trade $15.24 Trade Date: 9/9 Shares: 4.25 million Underwriter(s)Leerink Partners, RBC Capital Markets, H.C. Wainwright[…]

Scroll to top
error: Content is protected !!